Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
More metabolic issues link to early kidney damage in non-diabetic adults
-
Today's research did not include new kidney-specific studies; most focused on general health topics like heart disease or cancer without connecting to kidney outcomes.
Today's research sweep found no new studies directly about chronic kidney disease treatments or outcomes. One notable observational study linked cumulative metabolic burden to early signs of kidney damage in non-diabetic adults, but it does not prove cause and effect. Most other findings relate to dialysis improvements or unrelated health areas, offering little direct guidance for stage 3 kidney disease today.
Efficacy of desmopressin in reducing post-procedural bleeding among chronic kidney disease patients: a systematic review and meta-analysis.
Researchers pooled results from randomized trials, searching three medical databases through August 2025, to test whether the drug desmopressin cuts bleeding when people with chronic kidney disease have surgery or a procedure. Kidney disease makes the blood's clotting cells work poorly, so bleeding is a real risk. Desmopressin is already given for this, but doctors were not sure it worked. Pooling randomized trials is the strongest kind of evidence, so this gives a clearer answer than any single trial did.
Abdominal aortic calcification index and prognosis in patients with chronic kidney disease: a meta-analysis
This review pooled many earlier studies that scored calcium buildup in the main artery of the belly on scans in people with kidney disease. It asked whether a higher score goes with worse outcomes later, such as heart problems and death. The pooled studies watched people over time rather than testing a treatment, so the pattern is a strong link, not proof that the calcium itself does the harm. A scan score like this could help flag who needs closer watching.
Renal Safety of Intravitreal Ranibizumab and the Effects of SGLT2 Inhibition in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial.
This is a follow-up look at 53 people from the COMET randomized trial, all with swelling in the back of the eye from diabetes. Researchers checked whether eye injections of the drug ranibizumab affected the kidneys over 48 weeks, tracking kidney filtering rate (eGFR), protein in the urine, and red blood cell levels. They also checked whether SGLT2 inhibitor drugs showed their usual kidney and blood effects in this group. The study is small and was not designed to answer this question up front, so it is a safety signal check rather than firm proof.
Effects of Brussels Chicory and Concurrent Exercise Training on HDL Function and Subclass Profiles in Overweight College Students: A Pilot Randomized Controlled Trial.
This was a small pilot study in overweight college students who were split at random into three groups. One group took a supplement made from Brussels chicory, a leafy vegetable rich in plant compounds called phenolic acids. The other two added either supervised exercise or exercise with mindfulness training on top of the supplement. The report we have does not give the number of people or how long it ran, and it measured lab markers of good cholesterol function rather than any health outcome.
Cumulative metabolic burden and urinary albumin-to-creatinine ratio in non-diabetic adults: a nationwide population-based study.
This nationwide study looked at adults without diabetes and asked whether piling up metabolic problems over time tracks with early kidney damage. The damage marker is albumin in the urine, a protein that leaks out when the kidney's filters are strained. People with more metabolic burden had higher levels of that protein. This is an observational snapshot, so it shows a link, not proof that one causes the other.
Profile, follow-up adherence and progression of people with advanced chronic kidney disease in specialized care centers: a retrospective study, Santa Catarina state, Brazil, 2021-2024.
Researchers looked back at medical records from five kidney clinics in Santa Catarina, Brazil, covering people treated between November 2021 and October 2024. Everyone had stage 4 or stage 5 kidney disease, which is advanced. The team described who these patients were, how many kept coming to appointments, and how their kidney filtering rate (eGFR) changed after one year of specialist care. This kind of look-back study can show a link between staying in care and kidney results, but it cannot prove the care caused the difference.
Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry.
Doctors in Turkey reviewed records from the FINE-TURK registry to see how the drug finerenone performed in people who have type 2 diabetes, kidney disease and heart failure all at once. Finerenone is known to protect the heart and kidneys in diabetes with kidney disease, but people with heart failure were barely studied before. The report describes who these patients were and what happened to their kidneys over a short follow-up. It is a look-back at real-world records, so it shows patterns, not proof that the drug caused the results.
Sex differences in cardiac function and remodelling in patients with preserved left ventricular ejection fraction across all stages of chronic kidney disease.
Doctors reviewed heart scans from 84 people with kidney disease across all five stages, matched for sex, plus healthy people for comparison. Everyone had normal heart pumping strength, so the study looked instead at changes in the heart's shape and how it fills. Women and men with kidney disease showed different patterns of change. This is a look back at old records, so it shows a link between sex and heart changes, not proof that one causes the other.
Association of neutrophil-to-lymphocyte-platelet ratio with residual renal function in early-stage peritoneal dialysis patients.
This study tested a blood measure that combines three cell counts: neutrophils, lymphocytes and platelets. In people on peritoneal dialysis, a home form of dialysis, a higher number went along with less leftover kidney function of their own. Patients were split into a group on dialysis 3 to 12 months and a group past 12 months. It was a look back at medical records, so it shows a link, not proof that inflammation causes the loss.
Associations Among Caregiver Burden, Mindful Self-Care, and Health Perception in Informal Caregivers of Patients With Chronic Kidney Disease: A Cross-Sectional Study.
This study surveyed unpaid family caregivers of people with chronic kidney disease at a single point in time. It measured how heavy the caregiving load felt, how healthy caregivers rated themselves, and how much they practiced mindful self-care, meaning paying attention to their own needs on purpose. The researchers found these three things are linked to each other. A one-time survey shows a link only. It cannot tell us whether self-care makes caregivers healthier or whether healthier caregivers simply have more room for self-care.
Latent histopathological activation of the renin–angiotensin–aldosterone system in children with low birth weight
Researchers examined kidney tissue from children who were born small, at a low birth weight. They found quiet signs that the hormone system controlling blood pressure and salt, called the renin-angiotensin-aldosterone system, was switched on. That system is the target of common blood pressure drugs. This shows a link, not proof that low birth weight causes the change, and it is a preprint that other scientists have not checked yet.
Clinical characteristics and prognosis of IgA nephropathy and comorbid diabetic kidney disease
This study looked at people who have two kidney diseases at once: IgA nephropathy and diabetic kidney disease. IgA nephropathy is when the immune system damages the kidney's tiny filters. The researchers compared symptoms, lab results and later outcomes against people who had only one of the two conditions. It looks back at existing records, so it can show a link between having both diseases and how people did, not proof that one caused the other.
Plasma neurofilament light chain in type 2 diabetes: Associations with diabetic peripheral neuropathy, age, and renal function in a pilot cross-sectional study
This small study measured a blood marker of nerve damage, called neurofilament light chain, in people with type 2 diabetes. It checked whether the marker tracks with nerve damage in the hands and feet, with older age, and with the kidney filtering rate (eGFR). Everything was measured at one point in time, so it can show a link, not proof of cause. The authors call it a pilot, meaning a first look that needs a bigger study to confirm.
Vasculitis Syndromes with Renal Involvement: A Review from a Case Series.
This review explains vasculitis, which is inflammation of blood vessels, when it attacks the kidneys, using real patient cases. Two forms, microscopic polyangiitis and granulomatosis with polyangiitis, often move fast and can reach kidney failure within months. Other forms start with fever and high inflammation blood tests while kidney function still looks normal, and only a kidney biopsy finds them. Because it draws on a series of cases, it teaches patterns to watch for, not proof of which treatment works best.
A comparative real-world analysis of finerenone and steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
This study compares finerenone, a newer kidney and heart drug, with older drugs in the same family such as spironolactone. It uses real-world records of people with chronic kidney disease who were already taking these drugs, so it can show a link, not proof of cause. The full abstract was not available in this sweep, so how much better either drug did is not known yet.
Comprehensive Haematological Alterations in Chronic Kidney Disease: Pathophysiological Mechanisms and Clinical Implications in Patients Attending Private Hospitals in Baghdad
Doctors in Baghdad looked at blood test changes in people with chronic kidney disease at private hospitals. Kidney disease often lowers red blood cells, which causes tiredness and shortness of breath. This is a look-back study, so it shows a link between kidney disease and these blood changes, not proof of cause. It was posted to a public repository and has not passed peer review.
SGLT2 Inhibitors in Nephrolithiasis: Emerging Evidence and What Urologists Need to Know
This review pulls together what is known about SGLT2 inhibitors and kidney stones. SGLT2 inhibitors are diabetes drugs that also slow kidney decline. The evidence so far comes from watching patients rather than testing the drugs against stones directly, so it shows a link, not proof that these drugs prevent stones.
Cardio-Renal Interaction Between NT-proBNP and Renal Function Across Chronic Kidney Disease Stages in Patients with Heart Failure
This study looked at NT-proBNP, a blood marker of heart strain, in people with heart failure at different stages of kidney disease. Weak kidneys raise this marker on their own, which makes the heart test harder to read. It is an observational study, so it shows a link between kidney function and the marker, not proof of cause.
Random Urinary Calcium/Creatinine Ratio as a Predictor of Dehydration in Hypercalcemic and Normocalcemic Patients
This study tested whether one urine sample, comparing calcium against creatinine, can flag dehydration. Creatinine is a waste product used to judge how concentrated the urine is. It is an observational study, so it shows a link, not proof of cause. Spotting dehydration early matters because it can injure the kidneys.
Birth characteristics and growth outcome in children with nephropathic cystinosis compared with other chronic kidney disease entities prior to kidney replacement therapy
Researchers compared birth size and later growth in children with nephropathic cystinosis, a rare inherited disease that damages the kidneys, against children with other kinds of chronic kidney disease. All the children were still before dialysis or a transplant. The comparison points to differences in how these children grow, which matters because poor growth is a warning sign in childhood kidney disease. This is an observational study, so it shows a link and not proof of cause.